Paid Clinical Trials Mobile

Discover 193 paid clinical trials in Mobile, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 193

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Pensacola FL, New Orleans LA, Jackson MS, Birmingham ALshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

MilvexianA Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Mobile AL, Slidell LA, New Orleans LA, Houma LAshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

CLENPIQStudy Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy

Recruiting

PHASE1

PHASE2

Sponsor:

Ferring Pharmaceuticals

Location:

Mobile AL, Baltimore MD, Bronx NY, San Diego CA

Code:

NCT04113382

Conditions

Bowel Preparation

Eligibility Criteria

Sex: All

Age: 2 - 8

Healthy Volunteers: Not accepted

Interventions

CLENPIQ

MIRALAX

Sacituzumab Tirumotecan & PembrolizumabSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Mobile AL, Thomasville GA, Monroe LA, Shreveport LAshow 39 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sacituzumab tirumotecan

Capecitabine

DonanemabA Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Pensacola FL, Ridgeland MS, Baton Rouge LA, Fayette MSshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

GalcanezumabA Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Pensacola FL, Gulf Breeze FL, Flowood MS, Ridgeland MSshow 42 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

Sacituzumab vs. TreatmentA Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Mobile AL, New Orleans LA, Atlanta GA, Shreveport LAshow 32 more

Code:

NCT06459180

Conditions

Cervical Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Tirumotecan

Pemetrexed

Tisotumab Vedotin

Topotecan

Vinorelbine

Paclitaxel & IpatasertibStudy of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Mobile AL, Birmingham AL, Jacksonville FL, Houston TXshow 165 more

Code:

NCT05554380

Conditions

Locally Advanced Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Ipatasertib

Magnetic Resonance Imaging

Golcadomide & R-CHOPStudy to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

Recruiting

PHASE3

Sponsor:

Celgene

Location:

Mobile AL, Pensacola FL, Baton Rouge LA, Atlanta GAshow 42 more

Code:

NCT06356129

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Golcadomide

Placebo

Rituximab

Cyclophosphamide

Doxorubicin

NICU AntibioticsNICU Antibiotics and Outcomes Trial

Recruiting

Sponsor:

Michael Morowitz

Location:

Mobile AL, Tampa FL, Louisville KY, Winston-Salem NCshow 13 more

Code:

NCT03997266

Conditions

Microbial Colonization

Extreme Prematurity

Early-Onset Neonatal Sepsis

Late-Onset Neonatal Sepsis

Necrotizing Enterocolitis of Newborn

Eligibility Criteria

Sex: All

Age: 0 - 4

Healthy Volunteers: Not accepted

Interventions

Ampicillin

Gentamycin

Normal saline